
Dr. Amol Navathe, US Dept of Health and Human Services
Dr. Amol Navathe, MD, PhD, US Dept of Health and Human Services, discusses his paper and answers questions at the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC
KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials: Christof Vulsteke, MD, PhD
October 20th 2025Perioperative enfortumab vedotin plus pembrolizumab demonstrated significant results in a population that represents roughly half of all patients with MIBC, explained Christof Vulsteke, MD, PhD.
Read More
KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials: Christof Vulsteke, MD, PhD
October 20th 2025Perioperative enfortumab vedotin plus pembrolizumab demonstrated significant results in a population that represents roughly half of all patients with MIBC, explained Christof Vulsteke, MD, PhD.
Read More
2 Commerce Drive 
Cranbury, NJ 08512